This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AAPL CAT DELL IBM HPQ

PACCAR (PCAR) rated new Overweight at Piper. $48.50 price target. Best positioned to benefit from a return to growth in the North American truck market.

Pier 1 Imports (PIR) rated new Buy at Deutsche. $25 price target. Company is leveraged to positive industry trends.

Progressive (PRGS) downgraded at Mizuho from Buy to Neutral, Mizuho said. $14.50 price target. Company is losing a key leader, which it will struggle to replace.

Pioneer Natural (PXD) rated new Outperform at Wells. Wolfcamp play should drive near-term growth.

Questcor Pharmaceuticals (QCOR) upgraded at Jefferies to Buy from Hold, Jefferies said. $28 price target. Limited downside with improved visibility.

Vertex Pharmaceuticals (VRTX) rated new Buy at Deutsche. $77 price target. New cystic fibrosis drug should be the next main driver.


Moody's (MCO) estimates, target increased at Piper. MCO estimates were raised through 2013, Piper Jaffray said. Company is leveraged to higher debt issuance rates. Overweight rating and new $55 price target.

Pentair (PNR) estimates, target raised at Credit Suisse. Shares of PNR now seen reaching $54, according to Credit Suisse. Estimates also increased, as the Tyco deal should add to earnings. Neutral rating.

Riverbed (RVBD) estimates, target boosted at ThinkEquity. Shares of RVBD now seen reaching $26, according to ThinkEquity. Estimates also upped, given higher expected demand and pricing. Buy rating.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DELL $0.00 0.00%
AAPL $130.28 0.47%
CAT $84.60 -0.22%
HPQ $33.26 -0.36%
IBM $169.78 -0.27%


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs